UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups

Nature immunology, 2019-11, Vol.20 (11), p.1425-1434

2019

Volltextzugriff (PDF)

Interferon-γ: teammate or opponent in the tumour microenvironment?

Nature reviews. Immunology, 2022-03, Vol.22 (3), p.158-172

2022

Volltextzugriff (PDF)

LAG3 (CD223) as a cancer immunotherapy target

Immunological reviews, 2017-03, Vol.276 (1), p.80-96

2017

Volltextzugriff (PDF)

LAG-3 as the third checkpoint inhibitor

Nature immunology, 2023-09, Vol.24 (9), p.1415-1422

2023

Volltextzugriff (PDF)

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

Immunity (Cambridge, Mass.), 2020-01, Vol.52 (1), p.183-199.e9

2020

Volltextzugriff (PDF)

How regulatory T cells work

Nature reviews. Immunology, 2008-07, Vol.8 (7), p.523-532

2008

Volltextzugriff (PDF)

Co-stimulatory and Co-inhibitory Pathways in Autoimmunity

Immunity (Cambridge, Mass.), 2016-05, Vol.44 (5), p.1034-1051

2016

Volltextzugriff (PDF)

Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity

Nature immunology, 2020-09, Vol.21 (9), p.1010-1021

2020

Volltextzugriff (PDF)

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

Nature, 2007-11, Vol.450 (7169), p.566-569

2007

Volltextzugriff (PDF)

Once a Treg, always a Treg?

Immunological reviews, 2014-05, Vol.259 (1), p.173-191

2014

Volltextzugriff (PDF)

Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape

Cancer research (Chicago, Ill.), 2012-02, Vol.72 (4), p.917-927

2012

Volltextzugriff (PDF)

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

Nature communications, 2021-06, Vol.12 (1), p.3349-3349, Article 3349

2021

Volltextzugriff (PDF)

Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion

Nature immunology, 2019-06, Vol.20 (6), p.724-735

2019

Volltextzugriff (PDF)

LAG3 associates with TCR-CD3 complexes and suppresses signaling by driving co-receptor-Lck dissociation

Nature immunology, 2022-05, Vol.23 (5), p.757-767

2022

Volltextzugriff (PDF)

Inhibitory receptors as targets for cancer immunotherapy

European journal of immunology, 2015-07, Vol.45 (7), p.1892-1905

2015

Volltextzugriff (PDF)

Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing

Nature communications, 2021-12, Vol.12 (1), p.7338-7338, Article 7338

2021

Volltextzugriff (PDF)

Targeting regulatory T cells in tumors

The FEBS journal, 2016-07, Vol.283 (14), p.2731-2748

2016

Volltextzugriff (PDF)

The plasticity and stability of regulatory T cells

Nature reviews. Immunology, 2013-06, Vol.13 (6), p.461-467

2013

Volltextzugriff (PDF)

Autoreactive CD8 + T cells are restrained by an exhaustion-like program that is maintained by LAG3

Nature immunology, 2022-06, Vol.23 (6), p.868-877

2022

Volltextzugriff (PDF)

Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung

Nature immunology, 2020-11, Vol.21 (11), p.1371-1383

2020

Volltextzugriff (PDF)

Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?

The Journal of immunology (1950), 2016-11, Vol.197 (10), p.3762-3770

2016

Volltextzugriff (PDF)

Interleukin-35: odd one out or part of the family?

Immunological reviews, 2008-12, Vol.226 (1), p.248-262

2008

Volltextzugriff (PDF)

development and function of regulatory T cells

Cellular and molecular life sciences : CMLS, 2009-08, Vol.66 (16), p.2603-2622

2009

Volltextzugriff (PDF)

Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8+ T Cell-Derived Interferon-γ

Immunity (Cambridge, Mass.), 2019-08, Vol.51 (2), p.381-397.e6

2019

Volltextzugriff (PDF)

Human tolerogenic dendritic cells produce IL‐35 in the absence of other IL‐12 family members

European journal of immunology, 2015-06, Vol.45 (6), p.1736-1747

2015

Volltextzugriff (PDF)

1 – 25 von 386

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(370)
Mit Volltextzugriff
(318)

Publikationsform

Sprache

Englisch
(386)

Erscheinungsjahr

n.n

Thema

Science & Technology
(220)
Life Sciences & Biomedicine
(196)
Animals
(161)
Immunology
(147)
Mice
(135)
Humans
(124)
T-Lymphocytes, Regulatory - Immunology
(57)
Lymphocytes
(49)
Mice, Inbred C57bl
(49)
Immunotherapy
(47)
T-Lymphocytes - Immunology
(39)
Mice, Knockout
(37)
Cytokines
(34)
Mice, Transgenic
(34)
Female
(32)
Lymphocytes T
(31)
Signal Transduction
(31)
T Cells
(31)
Biochemistry & Molecular Biology
(30)
Cancer
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Immunology
(99)
The journal Of Immunology/the journal Of Immunology
(45)
Nature Immunology
(30)
Immunity
(14)
Journal For Immunotherapy Of Cancer
(13)
Clinical Cancer Research
(10)
European Journal Of Immunology
(9)
Cell
(8)
Diabetes
(8)
Nature
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups

Interferon-γ: teammate or opponent in the tumour microenvironment?

LAG3 (CD223) as a cancer immunotherapy target

LAG-3 as the third checkpoint inhibitor

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

How regulatory T cells work

Co-stimulatory and Co-inhibitory Pathways in Autoimmunity

Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

Once a Treg, always a Treg?

Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion

LAG3 associates with TCR-CD3 complexes and suppresses signaling by driving co-receptor-Lck dissociation

Inhibitory receptors as targets for cancer immunotherapy

Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing

Targeting regulatory T cells in tumors

The plasticity and stability of regulatory T cells

Autoreactive CD8 + T cells are restrained by an exhaustion-like program that is maintained by LAG3

Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung

Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?

Interleukin-35: odd one out or part of the family?

development and function of regulatory T cells

Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8+ T Cell-Derived Interferon-γ

Human tolerogenic dendritic cells produce IL‐35 in the absence of other IL‐12 family members

Suchergebnisse filtern